OBJECTIVES: Hypertrophic scars and keloids have high influence on quality of life for women after surgery and lead to strong psychosocial impairment. There are numbers of invasive and non-invasive options available for the plastic and aesthetic surgery both to prevent and to treat abnormal scar formation. The objective of this study was to estimate costs of treatment scheme of scars after surgery on mammary glands in real life practice and assess consumption of medicine in out-patient care in Ukraine. METHODS: We analyzed 47 medical records of women with scars after surgery on mammary glands at Lviv State Regional Oncology Diagnosing and Treating Centre in 2015 in Ukraine (Lviv Region population 2,5 mln people). We calculated the average costs of medicine treatment course per patient for 3 month duration; and we analyzed the direct cost of treatment using weighted average prices from Morion company database (Ukraine) as of December 1, 2016 (1 USD= 26 UAH) from patients’ perspective. RESULTS:  The main effectiveness outcomes in the scheme are lower recurrence rates, satisfied patients, absence of additional surgery of defect scars, and short time presence in hospital (Monstrey S., Middlekoop E. et al., 2014). The sample included 47 women with age ranging from 19 to 41 years. The treatment included: dexamethasone solution for injection, local anesthetic (2% lidocaine), silicone patch, elastic bandage. An average costs were 57.86 USD per one woman for treatment course for 3 month. CONCLUSIONS:  The costs of the treatment are high because they are the patient`s out-of-pocket expenses. The analysis shows the actual topic for research of women health and optimization of treatment regimens after surgery.